Genesco Inc (GCO) stock
Close on Oct 30, 2026Market cap $407.38MP/E –Yield –
Earnings
Genesco's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Genesco's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Nov 1, 2026 | Dec 3, 2026Expected | – | – | – | – | – |
| Q2 FY2027ended Aug 1, 2026 | Sep 3, 2026before the open | $530.00M | -2.9% | $0.32 | -$0.83 | Release |
| Q1 FY2027ended May 2, 2026 | May 29, 2026before the open | $487.00M | +2.7% | -$1.42 | -$2.18 | Release |
| Q4 FY2026ended Jan 31, 2026 | Mar 6, 2026before the open | $800.00M | +7.2% | $4.43 | $3.74 | Release |
| Q3 FY2026ended Nov 1, 2025 | Dec 4, 2025before the open | $616.00M | +3.4% | $0.51 | $0.79 | Release |
| Q2 FY2026ended Aug 2, 2025 | Aug 28, 2025before the open | $546.00M | +4.0% | -$1.79 | -$1.14 | Release |
| Q1 FY2026ended May 3, 2025 | Jun 4, 2025before the open | $474.00M | +3.5% | -$2.02 | -$2.05 | Release |
| Q4 FY2025ended Feb 1, 2025 | Mar 7, 2025before the open | $746.00M | +0.9% | $3.06 | $3.26 | Release |
| Q3 FY2025ended Nov 2, 2024 | Dec 6, 2024before the open | $596.00M | +2.9% | -$1.76 | $0.61 | Release |
| Q2 FY2025ended Aug 3, 2024 | Sep 6, 2024before the open | $525.00M | +0.4% | -$0.91 | -$0.83 | Release |
| Q1 FY2025ended May 4, 2024 | May 31, 2024before the open | $458.00M | -5.2% | -$2.22 | -$2.10 | Release |
| Q4 FY2024ended Feb 3, 2024 | Mar 8, 2024before the open | $739.00M | +1.9% | $1.84 | $2.59 | Release |
| Q3 FY2024ended Oct 28, 2023 | Dec 1, 2023before the open | $579.00M | – | $0.60 | $0.57 | Release |
| Q2 FY2024ended Jul 29, 2023 | Aug 31, 2023before the open | $523.00M | – | -$2.79 | -$0.85 | Release |
| Q1 FY2024ended Apr 29, 2023 | May 25, 2023before the open | $483.00M | -7.3% | -$1.60 | -$1.59 | Release |
| Q4 FY2023ended Jan 28, 2023 | Mar 9, 2023before the open | $725.00M | -0.4% | $3.23 | $3.06 | Release |
| Q1 FY2023ended Apr 30, 2022 | May 26, 2022before the open | $521.00M | – | $0.37 | $0.44 | Release |
| Q4 FY2022ended Jan 29, 2022 | Mar 10, 2022before the open | $728.00M | – | $4.41 | $3.48 | Release |
| Q3 FY2022ended Oct 30, 2021 | Dec 3, 2021before the open | $601.00M | – | $2.26 | $2.36 | Release |
| Q2 FY2022ended Jul 31, 2021 | Sep 2, 2021before the open | – | – | – | – | Filing |
| Q1 FY2022ended May 1, 2021 | May 27, 2021before the open | – | – | – | – | Filing |
| Q4 FY2021ended Jan 30, 2021 | Mar 11, 2021before the open | – | – | – | – | Filing |
| Q3 FY2021ended Oct 31, 2020 | Dec 4, 2020before the open | – | – | – | – | Filing |
| Q2 FY2021ended Aug 1, 2020 | Sep 3, 2020before the open | – | – | – | – | Filing |
| Q1 FY2021ended May 2, 2020 | Jun 9, 2020before the open | – | – | – | – | Filing |
| Q4 FY2020ended Feb 1, 2020 | Mar 12, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Genesco's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| tax rate | Q3 FY2027 | 7% – 8% | 7% – 8% | Reaffirmed | Sep 3, 2026 |
| total sales | FY2027 | -2% | – | New | Sep 3, 2026 |
| positive comparable sales | FY2027 | +1% – +2% | +1% – +2% | Reaffirmed | May 29, 2026 |
| Operating income | FY2027 | $34.00M – $40.00M | – | New | Sep 3, 2026 |
| Forecasted earnings from continuing operations per shareGAAP | FY2027 | $2.96 – $3.39 | $2.32 – $2.75 | Raised | Sep 3, 2026 |
| Adjusted diluted earnings per share from continuing operationsnon-GAAP | FY2027 | $2.00 – $2.40 | $2.00 – $2.40 | Reaffirmed | Sep 3, 2026 |
| tax rate | FY2027 | 30% | 30% | Reaffirmed | Sep 3, 2026 |
Guidance vs results
The last range Genesco gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | adjusted diluted earnings per share from continuing operations | $0.95 | $1.34Σ4Q | Above range |
| FY2026 | EPS (GAAP) | $0.48 | $1.13Σ4Q | Above range |
| FY2026 | Revenue growth | +2% | +4.77%Σ4Q | Above range |
| FY2025 | adjusted diluted earnings per share from continuing operations | $0.80 – $1.00 | $0.94Σ4Q | Within range |
| FY2025 | EPS (GAAP) | $0.53 – $0.76 | -$1.83Σ4Q | Below range |
Guidance history
Every forecast Genesco put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Sep 3, 2026 | Adjusted diluted earnings per share from continuing operations | FY2027 | $2.00 – $2.40 | Reaffirmed |
| Sep 3, 2026 | Forecasted earnings from continuing operations per share | FY2027 | $2.96 – $3.39 | Raised |
| Sep 3, 2026 | Operating income | FY2027 | $34.00M – $40.00M | New |
| Sep 3, 2026 | tax rate | FY2027 | 30% | Reaffirmed |
| Sep 3, 2026 | tax rate | Q3 FY2027 | 7% – 8% | Reaffirmed |
| Sep 3, 2026 | total sales | FY2027 | -2% | New |
| May 29, 2026 | positive comparable sales | FY2027 | +1% – +2% | Reaffirmed |
| May 29, 2026 | adjusted diluted earnings per share from continuing operations | FY2027 | $2.00 – $2.40 | Raised |
| May 29, 2026 | Forecasted earnings from continuing operations | FY2027 | $2.32 – $2.75 | Raised |
| May 29, 2026 | tax rate | FY2027 | 30% | New |
| May 29, 2026 | tax rate | Q2 FY2027 | 7% – 8% | New |
| May 29, 2026 | tax rate | Q3 FY2027 | 7% – 8% | New |
| Mar 6, 2026 | positive comparable sales | FY2027 | +1% – +2% | New |
| Mar 6, 2026 | adjusted diluted earnings per share from continuing operations | FY2027 | $1.90 – $2.30 | New |
| Mar 6, 2026 | Forecasted earnings from continuing operations | FY2027 | $2.12 – $2.55 | New |
| Dec 4, 2025 | comparable sales | FY2026 | +3% | Lowered |
| Dec 4, 2025 | adjusted diluted earnings per share from continuing operations | FY2026 | $0.95 | Lowered |
| Dec 4, 2025 | Forecasted earnings from continuing operations | FY2026 | $0.48 | Lowered |
| Dec 4, 2025 | total sales | FY2026 | +2% | Lowered |
| Aug 28, 2025 | comparable sales | FY2026 | +4% – +5% | Raised |
| Aug 28, 2025 | adjusted diluted earnings per share from continuing operations | FY2026 | $1.30 – $1.70 | Reaffirmed |
| Aug 28, 2025 | tax rate excluding the tax impact of OBBBA | FY2026 | 29% | New |
| Aug 28, 2025 | total sales | FY2026 | +3% – +4% | Raised |
| Jun 4, 2025 | comparable sales | FY2026 | +2% – +3% | New |
| Jun 4, 2025 | adjusted diluted earnings per share from continuing operations | FY2026 | $1.30 – $1.70 | Reaffirmed |
| Jun 4, 2025 | tax rate | FY2026 | 29% | New |
| Jun 4, 2025 | total sales | FY2026 | +1% – +2% | New |
| Mar 7, 2025 | adjusted diluted earnings per share from continuing operations | FY2026 | $1.30 – $1.70 | New |
| Mar 7, 2025 | Forecasted earnings from continuing operations | FY2026 | $1.18 – $1.61 | New |
| Dec 6, 2024 | adjusted diluted earnings per share from continuing operations | FY2025 | $0.80 – $1.00 | New |
| Dec 6, 2024 | Forecasted earnings from continuing operations | FY2025 | $0.53 – $0.76 | New |
| Sep 6, 2024 | adjusted diluted earnings per share from continuing operations | FY2025 | $0.60 – $1.00 | Reaffirmed |
| Sep 6, 2024 | total sales | FY2025 | -2% – -1% | Raised |
| May 31, 2024 | adjusted diluted earnings per share from continuing operations | FY2025 | $0.60 – $1.00 | Reaffirmed |
| May 31, 2024 | total sales | FY2025 | -3% – -2% | New |
| Mar 8, 2024 | adjusted diluted earnings per share from continuing operations | FY2025 | $0.60 – $1.00 | New |
| Mar 8, 2024 | Forecasted earnings from continuing operations | FY2025 | $0.48 – $0.92 | New |
| Mar 8, 2024 | total sales | FY2025 | -3% – -2% | New |
| Mar 8, 2024 | total sales excluding the 53 rd week in Fiscal 2024 | FY2025 | -2% – -1% | New |
| Dec 1, 2023 | adjusted diluted earnings per share from continuing operations | FY2024 | $1.50 – $2.00 | Lowered |
| Dec 1, 2023 | sales | FY2024 | -2% – -1% | Raised |
| Dec 1, 2023 | sales excluding the 53 rd week | FY2024 | -3% – -2% | New |
| Aug 31, 2023 | adjusted diluted earnings per share from continuing operations | FY2024 | $2.00 – $2.50 | Reaffirmed |
| Aug 31, 2023 | sales | FY2024 | -4% – -2% | Raised |
| May 25, 2023 | Adjusted diluted earnings per share from continuing operations | FY2024 | $2.00 – $2.50 | Lowered |
| May 25, 2023 | Sales | FY2024 | -5% – -4% | New |
| Mar 9, 2023 | Adjusted diluted earnings per share from continuing operations | FY2024 | $5.10 – $5.90 | New |
| Mar 9, 2023 | Forecasted earnings from continuing operations | FY2024 | $4.99 – $5.82 | New |
| May 26, 2022 | Adjusted diluted earnings per share from continuing operations | FY2023 | $7.00 – $7.75 | Reaffirmed |
| May 26, 2022 | Sales | FY2023 | +1% – +3% | Lowered |
| Mar 10, 2022 | Adjusted diluted earnings per share from continuing operations | FY2023 | $7.00 – $7.75 | New |
| Mar 10, 2022 | tax rate | FY2023 | 27% – 28% | New |
| Mar 10, 2022 | Sales | FY2023 | +2% – +4% | New |
| Dec 3, 2021 | Adjusted diluted earnings per share from continuing operations | FY2022 | $6.40 – $6.90 | New |
| Dec 3, 2021 | Sales | FY2022 | +9% – +11% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Genesco filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results